MNV
Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

OPKO Health is Now Oversold (OPK)
Thursday, January 18, 1:12 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

ALXN Makes Notable Cross Below Critical Moving Average
Tuesday, January 30, 11:54 AM ET, by Market News Video Staff

In trading on Tuesday, shares of Alexion Pharmaceuticals Inc. (ALXN) crossed below their 200 day ...

Add Up The Pieces: PBE Could Be Worth $57
Monday, February 5, 9:55 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Oversold Conditions For Repligen
Monday, February 5, 12:07 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Bruker Reaches Analyst Target Price
Wednesday, February 7, 9:49 AM ET, by Market News Video Staff

In recent trading, shares of Bruker Corp (BRKR) have crossed above the average analyst 12-month ...

Snag This Deal Even Lower Than Director Laukien Did

By Market News Video Staff, Thursday, September 20, 1:41 PM ET
Play Video: One Reason For Insiders to Buy


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 14, Bruker Corp's Director, Joerg C. Laukien, invested $1,300,000.00 into 100,000 shares of BRKR, for a cost per share of $13.00. Bargain hunters tend to pay particular attention to insider buys like this one, because presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money.

In trading on Thursday, bargain hunters could buy shares of Bruker Corp (NASDAQ:BRKR) and achieve a cost basis 1.4% cheaper than Laukien, with shares changing hands as low as $12.82 per share. Bruker Corp shares are currently trading off about 4% on the day. The chart below shows the one year performance of BRKR shares, versus its 200 day moving average:

Bruker Corp Chart

Looking at the chart above, BRKR's low point in its 52 week range is $9.91 per share, with $17.10 as the 52 week high point that compares with a last trade of $12.83. By comparison, below is a table showing the prices at which insider buying was recorded over the last six months:

Purchased Insider Title Shares Price/Share Value
09/14/2012 Joerg C. Laukien Director 100,000 $13.00 $1,300,000.00
09/14/2012 Frank H. Laukien CEO/President 100,000 $13.00 $1,300,000.00

According to the ETF Finder at ETF Channel, BRKR makes up 2.82% of the Dynamic Biotechnology & Genome Portfolio ETF (AMEX:PBE) which is trading relatively unchanged on the day Thursday.

See what other ETFs contain BRKR
See what other stocks are held by PBE


Special Offer: Establish a secure stream of income during your retirement years by following the Retiree Income Portfolio with this free 30 day trial


This Article's Word Cloud:   AMEX   According   BRKR   Back   Bargain   Bargains   Biotechnology   Bruker   Channel   Cheaper   Corp   Director   Dynamic   ETFs   Establish   Finder   Frank   Genome   Income   Insider   Insiders   Joerg   Laukien   Looking   Offer   Portfolio   Thursday   about   below   buying   chart   cost   hunters   insider   last   only   other   point   reason   share   shares   stock   that   their   this   trading   week   what   which   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

Snag This Deal Even Lower Than Director Laukien Did | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.